title: Lineage switch induced by overexpression of Ets family transcription factor PU.1 in murine erythroleukemia cells.
abstract: PU.1 is an Ets family transcription factor essential for myelomonocyte and B-cell development. We previously showed that overexpression of PU.1 in murine erythroleukemia (MEL) cells inhibits growth and erythroid differentiation and induces apoptosis of the cells. In an effort to identify target genes of PU.1 concerning these phenomena by using a messenger RNA differential display strategy, we found that some myeloid-specific and lymphoid-specific genes, such as the osteopontin gene, are transcriptionally up-regulated in MEL cells after overexpression of PU.1. We then found that expression of several myelomonocyte-specific genes, including the CAAT-enhancer-binding protein-alpha and granulocyte-macrophage colony-stimulating factor receptor genes, was induced in MEL cells after overexpression of PU.1. B-cell-specific genes were also examined, and expression of the CD19 gene was found to be induced. Expression of the myelomonocyte-specific proteins CD11b and F4/80 antigen but not the B-cell-specific proteins B220 and CD19 was also induced. After overexpression of PU.1, MEL cells became adherent and phagocytic and showed enhanced nitroblue tetrazolium reduction activity. Expression of myelomonocyte-specific and B-cell-specific genes was not induced when a mutant PU.1 with part of the activation domain deleted (a change found to inhibit erythroid differentiation of MEL cells) was expressed. These results indicate that PU.1 induces a lineage switch in MEL cells toward myelomonocytic cells and that its activation domain is essential for this effect. The results also suggest that the pathway of the lineage switch is distinct from that of inhibition of erythroid differentiation in MEL cells.
authors: Department of Cell Genetics, Sasaki Institute, and the Department of Pathology, Juntendo University School of Medicine, Tokyo, Japan.
authors: T
authors: T
authors: Yamada
authors: M
authors: M
authors: Abe
authors: T
authors: T
authors: Higashi
authors: H
authors: H
authors: Yamamoto
authors: F
authors: F
authors: Kihara-Negishi
authors: T
authors: T
authors: Sakurai
authors: T
authors: T
authors: Shirai
authors: T
authors: T
authors: Oikawa
mesh_terms: D002448:Cell Adhesion; D002454:Cell Differentiation; D019070:Cell Lineage / Q000235:genetics*; D048429:Cell Size; D002712:Chlorides / Q000494:pharmacology; D020869:Gene Expression Profiling; D015973:Gene Expression Regulation, Leukemic / Q000187:drug effects; D004915:Leukemia, Erythroblastic, Acute / Q000235:genetics / Q000473:pathology*; D009363:Neoplasm Proteins / Q000096:biosynthesis* / Q000235:genetics; D014411:Neoplastic Stem Cells / Q000187:drug effects / Q000378:metabolism; D017434:Protein Structure, Tertiary; D011518:Proto-Oncogene Proteins / Q000096:biosynthesis / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D012333:RNA, Messenger / Q000096:biosynthesis* / Q000235:genetics; D012334:RNA, Neoplasm / Q000096:biosynthesis* / Q000235:genetics; D011993:Recombinant Fusion Proteins / Q000502:physiology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013382:Subtraction Technique; D015534:Trans-Activators / Q000096:biosynthesis / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D014158:Transcription, Genetic; D017967:Zinc Compounds / Q000494:pharmacology; D000099232:Proto-Oncogene Protein Spi-1
chemical_list: D002712:Chlorides; D009363:Neoplasm Proteins; D011518:Proto-Oncogene Proteins; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D011993:Recombinant Fusion Proteins; D015534:Trans-Activators; D017967:Zinc Compounds; D000099232:Proto-Oncogene Protein Spi-1; C016837:zinc chloride